Clinical Trial Update: Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC [Phase 2]

View source ↗

Summary

Phase 2 study of RP2 in combination with second-line therapy for locally advanced or metastatic hepatocellular carcinoma and biliary tract cancer, currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• RP2

Snippet

Sponsor: Replimune, Inc. | Conditions: Hepatocellular Carcinoma, Biliary Tract Cancer | Phase 2 | Status: RECRUITING